Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03307785 |
| Title | Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Scottsdale | Arizona | 85258 | United States | Details | |
| GSK Investigational Site | Encinitas | California | 92024 | United States | Details | |
| GSK Investigational Site | Sarasota | Florida | 34232 | United States | Details | |
| GSK Investigational Site | Canton | Ohio | 44718 | United States | Details | |
| GSK Investigational Site | Cleveland | Ohio | 44106 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | San Marcos | Texas | 92069 | United States | Details |